Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

HNX:MKV Revenue

Cai Lay Veterinary Pharmaceutical JSC had revenue of 42.16B VND in the quarter ending September 30, 2025, with 53.96% growth. This brings the company's revenue in the last twelve months to 134.14B, up 22.48% year-over-year. In the year 2024, Cai Lay Veterinary Pharmaceutical JSC had annual revenue of 107.04B, down -3.49%.

• Revenue (ttm): 134.14B
• Revenue Growth: +22.48%
• P/S Ratio: 0.56
• Revenue / Employee: 1.29B
• Employees: 104
• Market Cap: 75.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	107.04B	-3.87B	-3.49%
Dec 31, 2023	110.91B	-8.73B	-7.30%
Dec 31, 2022	119.63B	17.22B	16.82%
Dec 31, 2019	102.41B	-32.17B	-23.90%
Dec 31, 2018	134.58B	101.66B	308.87%